Welcome to our dedicated page for Goodrx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on Goodrx Holdings stock.
GoodRx Holdings, Inc. operates a digital healthcare platform focused on prescription and medication savings in the United States. Company news commonly covers prescription transaction revenue, retail pharmacy trends, negotiated discount pricing, PBM relationships, and the expansion of Pharma Direct manufacturer programs that connect branded drug discounts to consumers at the pharmacy counter.
GoodRx updates also include self-pay pricing arrangements for GLP-1 and other branded medications, subscription health services such as condition-specific programs, earnings releases, business outlook commentary, and partnerships with pharmaceutical manufacturers, pharmacies, payers, and healthcare professionals.
GoodRx (Nasdaq: GDRX) has entered a new direct contracting agreement with The Kroger Co. to offer enhanced prescription savings at over 2,200 Kroger pharmacy locations nationwide.
Starting June 1, 2024, patients using a GoodRx coupon can expect almost 50% more savings on most generic medications.
This partnership aims to support Kroger's business objectives and improve patients' access to affordable prescriptions.
GoodRx will discuss this agreement during its Investor Day on May 15 at 9 a.m. ET.
GoodRx Holdings, Inc. reported financial results for the first quarter of 2024. Revenue increased by 8% to $197.9 million, with a net loss of $1.0 million. Adjusted EBITDA was $62.8 million. The company focuses on capital allocation, share repurchases, and M&A. GoodRx anticipates revenue growth for the second quarter and full year 2024.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.